Search

Your search keyword '"Smith, U"' showing total 15 results
Start Over Author "Smith, U" Language swedish
15 results on '"Smith, U"'

1. [Warning against uncritical use of overweight surgery in type 2 diabetes].

Author

Agardh CD, Ahrén B, Hanås R, Jansson S, Smith U, Toft E, and Ostenson CG

Subjects
Body Mass Index, Diabetes Mellitus, Type 2 metabolism, Humans, Obesity metabolism, Bariatric Surgery adverse effects, Bariatric Surgery psychology, Diabetes Mellitus, Type 2 surgery, Obesity surgery
Published
2012

2. [Reply on new drugs against type 2 diabetes: important to gain experience and knowledge].

Author

Sjöholm A, Agardh CD, Brismar K, Efendic S, Eliasson B, Eriksson JW, Frid A, Groop L, Holmgren J, Ridderstråle M, and Smith U

Subjects
Drug Monitoring, Exenatide, Humans, Hypoglycemic Agents administration & dosage, Hypoglycemic Agents adverse effects, Insulin administration & dosage, Insulin therapeutic use, Peptides administration & dosage, Peptides adverse effects, Peptides therapeutic use, Pyrazines administration & dosage, Pyrazines adverse effects, Pyrazines therapeutic use, Sitagliptin Phosphate, Triazoles administration & dosage, Triazoles adverse effects, Triazoles therapeutic use, Venoms administration & dosage, Venoms adverse effects, Venoms therapeutic use, Diabetes Mellitus, Type 2 drug therapy, Hypoglycemic Agents therapeutic use
Published
2008

4. [Prevention of dyslipidemia--the foremost challenge in the management of diabetes].

Author

Smith U and Taskinen MR

Subjects
Cost-Benefit Analysis, Diabetes Mellitus blood, Diabetes Mellitus economics, Diabetes Mellitus, Type 2 blood, Diabetes Mellitus, Type 2 drug therapy, Diabetes Mellitus, Type 2 economics, Humans, Hyperlipidemias complications, Hyperlipidemias economics, Hypolipidemic Agents administration & dosage, Risk Factors, Diabetes Mellitus drug therapy, Hyperlipidemias prevention & control
Abstract

The most common lipid abnormalities in diabetes, particularly in type II diabetes, are increased levels of triglycerides and reduced levels of HDL (high-density lipoprotein) cholesterol. Recent findings have shown lipid abnormalities to be manifest at an early stage, long before glucose tolerance has become impaired. Much available evidence suggests intensive diabetes therapy to be cost-effective and of importance in preventing micro- and macrovascular complications.

Published
1999

5. [An extensive study gives a hope for better control of type 2 diabetes mellitus].

Author

Berne C and Smith U

Subjects
Controlled Clinical Trials as Topic, Diabetes Mellitus, Type 2 diagnosis, Diabetes Mellitus, Type 2 therapy, Diabetic Angiopathies prevention & control, Humans, Hypertension diagnosis, Hypertension drug therapy, Hypertension etiology, Prospective Studies, United Kingdom, Diabetes Mellitus, Type 2 complications
Published
1998

7. [Good diabetic control is worthwhile].

Author

Jönsson B and Smith U

Subjects
Cost-Benefit Analysis, Diabetes Complications, Diabetes Mellitus therapy, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 economics, Diabetes Mellitus, Type 2 therapy, Humans, Risk Factors, Cost of Illness, Diabetes Mellitus economics, Global Health
Published
1997

10. [Human insulin and risk of hypoglycemia].

Author

Smith U

Subjects
Humans, Hypoglycemia diagnosis, Insulin administration & dosage, Risk Factors, Hypoglycemia etiology, Insulin adverse effects
Published
1992

12. [Beta blockade and diabetes mellitus].

Author

Lager I and Smith U

Subjects
Adrenergic beta-Antagonists pharmacology, Catecholamines metabolism, Glucose Tolerance Test, Hemodynamics drug effects, Humans, Hypoglycemia physiopathology, Insulin metabolism, Insulin Secretion, Adrenergic beta-Antagonists adverse effects, Diabetes Mellitus drug therapy, Diabetes Mellitus physiopathology
Published
1981

14. [Cell surface receptors and their disorders].

Author

Bergström K, Boberg J, Dahlberg PA, Hall K, Johansson SG, Karlsson A, Smith U, and Wiman K

Subjects
Diabetes Mellitus etiology, Humans, Hypercholesterolemia etiology, Hypersensitivity, Immediate etiology, Hyperthyroidism etiology, Myasthenia Gravis etiology, Cell Membrane physiology, Receptors, Cell Surface physiology, Receptors, Cholinergic physiology, Receptors, Immunologic physiology
Published
1981

Catalog

Books, media, physical & digital resources
See catalog results